Introduction: This study was conducted to identify the enzymatic mechanism of carbapenem resistance in A. baumannii isolated from intensive
Introduction
Acinetobacter baumannii has emerged as a leading cause of nosocomial infections, particularly among critically ill patients in intensive care units [1, 2] A. baumannii clinical isolates are commonly resistant to multiple antimicrobial drug classes and have the ability to survive in the environment for prolonged periods of time, which facilitates their persistence in hospitals and make them a frequent cause of hospital outbreaks and an endemic healthcare associated pathogens [3] . Carbapenems have been widely used to treat these infections [4] , but a trend of increasing resistance to this antibiotic class has been reported worldwide [5] ; limiting drastically the range of therapeutic alternatives. Carbapenem resistance in A.
baumannii results mainly from beta-lactamases production [6, 7] .
Metallo-beta-lactamases are prevalent in East Asia and Western
Europe and confer resistance to all beta-lactams except aztreonam [1] . However, the OXA-type carbapenemases have emerged as the most widespread beta-lactamases with carbapenemase activity [8, 9] . These enzymes can be sub-devised into 5 distinct groups: OXA-72), OXA-58-like and OXA-143 [10] [11] [12] [13] . In addition to betalactamases, carbapenem resistance in A. baumannii may also result from porin or penicillin-binding protein modifications [5] . The aim of this study was to determine the enzymatic mechanism of carbapenem resistance in A. baumannii isolates recovered from intensive care units of two teaching hospitals (Tunisia and Algeria) and to characterize nosocomial outbreaks by antibiotyping and pulsed-field gel electrophoresis (PFGE). Screening for MBL-producing strains: Detection of MBL was done by double disk synergy test using an imipenem disk placed 10 mm from a disk saturated with 5µl of EDTA (0.5 M pH 8). An enlargement of the inhibition zone of imipenem facing the disk of EDTA was considered as a positive test [15] .
Methods

PCR amplification and sequencing:
BlaOXA-24-like, blaOXA-23-like and blaOXA-58-like genes were detected by PCR simplex assays as previously described [16] . 
Pulsed-field gel electrophoresis (PFGE): Molecular typing of
isolates was carried out, as described previously by Pulsed-Field Gel Electrophoresis (PFGE) using ApaI (Invitrogen) restriction endonuclease [14] . The ApaI restriction profiles were compared by visual inspection according to the criteria proposed by Tenover et al [17] .
Results
All strains were co-resistant to all β-lactams, gentamicin, amikacin, ciprofloxacin but remained susceptible to colistin. They showed high level of resistance to ticarcillin (MIC50>2048 μg/mL), ticarcillinclavulanic acid (MIC50>1024 μg/mL), aztreonam (MIC50 ≥256 μg/mL), ceftazidim (MIC50=2048 μg/mL), imipenem (MIC50= 256 μg/mL), meropenem (MIC50=128 μg/mL) and cefepime (MIC50=128 μg/mL) ( Figure 1B ). The genotype A was the most prevalent (12 strains) with 3 pulsotypes A1 (n=8), A2
(n=3) and A3 (n=1). However, the Algerian strains were clustered in one pattern G ( Figure 1A ).
Discussion
A. baumannii has been stealthily gaining ground as an agent of serious nosocomial infections, including bacteremia, pneumonia, urinary tract and wound infections [18] . Historically, it has been associated with opportunistic infections; the last two decades have seen an increase in both the incidence and seriousness of A.
baumannii infection, with the main targets being immunocompromized patients in intensive-care units [19] . The increase in A. baumannii infections has paralleled the alarming development of resistance [20] . Actually, multidrug-resistant A.
baumannii is recognized to be among the most difficult antimicrobial-resistant Gram-negative bacilli to control and treat, especially if isolates are resistant to the carbapenem class of antimicrobial agents [21] . This study aimed to investigate the enzymatic mechanism of 27 carbapenem resistant A.
baumannii clinical strains causing nosocomial infections in 27 debilitated patients hospitalized in two intensive care units of 2 different hospitals. As it was previously reported they mainly caused pneumonia and bacteremia [22, 23] . The known risk factors for acquisition of A. baumannii infections are length of intensive care unit [6] stay, use of central venous catheters, antibiotic use especially extended spectrum β-lactams and fluoroquinolones, urinary catheters and comorbidities [24] . In the present study, for all patients' length of hospital stay exceeded 6 days (6 to 90 days) and 18 of them were previously hospitalized. Empiric antibiotherapy based on cephalosporin 3 rd generation (N=11), amoxicillin/clavulanique acid (N=14) and imipenem (N=2) in association with aminosides or fluoroquinolones was noted in 11, 14 and 2 cases, respectively. Clinical outcome was favorable for only 1/3 of patients.
All strains were co-resistant to all β-lactams, gentamicin, amikacin, ciprofloxacin but 6 isolates remained susceptible to netilmicin, 2
isolates to tobramycin and 3 strains to trimethoprimsulfamethoxazol. All strains were susceptible to colistin. Despite its renal toxicity, colistin has become useful antibiotic for treating infections caused by carbapenem resistant pathogens [25] , but dissemination of A. baumannii resistant to colistin is worrying. In another side, many studies provide the activity of tigecycline against multidrug A. baumannii clinical isolates [26] . Antibiotic resistance in A. baumannii is frequently an interplay between several different mechanisms [5] . This bacteria produces naturally 2 intrinsic types of β-lactamases [5] . An AmpC type cephalosporinase expressed at a basal level and an oxacillinase represented by the OXA-51/69
variants [5] . When ISAba1 were inserted upstream of blaAmpC and blaOXA-51-like genes, the strains become resistant to ceftazidime and to carpenems, respectively [27, 28] . The blaOXA-51-like genes are chromosomally located in all of the A. baumannii isolates studied to date and their presence has been used to confirm identification of A.
baumannii [29] . In addition to those naturally occurring β- [30] . The gene encoding this enzyme, named ARI-1, was plasmid born and was associated with the ISAbaI transposase [30] . Since then, the IS-OXA23 structure has been found among Acinetobacter isolates from various countries [31, 32] . The bla OXA-23 genes have been identified as part of transposon structures, namely Tn2006 and Tn2007 [31] .
Interestingly, the reservoir (natural producer) of this gene has been identified as being A. radioresistens [33] . This Acinetobacter species shares the same reservoir with A. baumannii, the skin flora in humans [31] .
Our study revealed the presence of this carbapenemase in Tunisian (n=18) and Algerian (n=5) strains. However, blaOXA-24-like and bla OXA -58-like were not detected in any of ours strains. In the 4 strains, where only blaOXA-51 was detected, resistance can be explained by non enzymatic mechanisms or insertion of ISAba1 sequences [28, 34] . MBLs are powerful carbapenemases [35] . They have been identified worldwide in A. baumannii [36, 37] . 
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